Skip to main content

Advertisement

SpringerLink
Log in

Community-acquired methicillin-resistant Staphylococcus aureus: Epidemiology and potential virulence factors

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has been isolated from patients in the community. Some of these strains may have origins in the hospital, but others appear to be novel and unrelated to known hospital strains. Community MRSA strains have several distinguishing characteristics that may enable them to more readily colonize and infect otherwise healthy individuals. This article reviews recent publications addressing the epidemiology of MRSA in the community, risk factors associated with carriage, potentially associated virulence factors, and concepts of strain fitness as they pertain to MRSA. MRSA likely will be an increasingly important pathogen in the community.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Chambers HF: The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis 2001, 7:1–5.

    Google Scholar 

  2. Hiramatsu K, Longzhu C, Kuroda M, Ito T: The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001, 9:486–493. This is a very readable review of the molecular genetics of MRSA. This article focuses on the SCCmec element and its makeup, its genetic and phenotypic variability across the staphylococci, and how these can be used to gain an understanding of the evolution of MRSA.

    Article  PubMed  CAS  Google Scholar 

  3. Hiramatsu K, Okuma K, Ma XX, et al.: New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community. Curr Opin Infect Dis 2002, 15:407–413.

    PubMed  CAS  Google Scholar 

  4. Okuma K, Iwakawa K, Turnidge JD, et al.: Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002, 40:4289–4294.

    Article  PubMed  CAS  Google Scholar 

  5. Eady EA, Cove JH: Staphylococcal resistance revisited: community-acquired methicillin-resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003, 16:103–124. This is an excellent review of the literature regarding communityacquired MRSA. It includes sections on genes implicated in pathogenesis, origins of type IV SCCmec and community-acquired MRSA, and considerations in antibiotic treatment. This article includes several useful summary tables and has a very complete reference list.

    PubMed  CAS  Google Scholar 

  6. Garner JS, Jarvis WR, Emori TG, et al.: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128–140.

    Article  PubMed  CAS  Google Scholar 

  7. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, et al.: Reappraisal of community-acquired bacteremia: A proposal for a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 2002, 34:1431–1439.

    Article  PubMed  Google Scholar 

  8. Saïd-Salim B, Mathema B, Kreiswirth BN: Communityacquired-methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol 2003, 24:451–455. These authors use the results of genotyping studies (pulsed-field gel electrophoresis and DNA sequence analysis of the spa protein A gene) to support their proposal to subgroup community-onset MRSA into those isolated from patients with health care-associated risk factors and those without such risk factors. The former group is resistant to beta-lactams alone or beta-lactams plus erythromycin, and the latter also is commonly resistant to clindamycin and the fluoroquinolones. Both groups carry SCCmec type IV, but they differ in the chromosomal backgrounds into which the SCCmec element is inserted. The authors also report some clinical-epidemiologic data to support this.

    Article  PubMed  Google Scholar 

  9. Salgado CD, Farr BM, Calfee DP: Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clin Infect Dis 2003, 36:131–139. This paper provides a thorough review of the epidemiologic literature regarding community MRSA, with a useful stratification according to the types and locations of the studies included. The authors note a high prevalence of health care-associated risk factors in most subjects studied and conclude that control of MRSA in the community will depend on control of its transmission in the nosocomial setting.

    Article  PubMed  Google Scholar 

  10. Nimmo G, Schooneveldt J, O’Kane G, et al.: Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. J Clin Microbiol 2000, 38:3926–3931.

    PubMed  CAS  Google Scholar 

  11. Laurent F, Lelièvre H, Cornu M, et al.: Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J Antimicrob Chemother 2001, 47:277–283.

    Article  PubMed  CAS  Google Scholar 

  12. Gosbell IB, Mercer JL, Neville SA, et al.: Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in South Western Sydney. Pathology 2001, 33:206–210.

    Article  PubMed  CAS  Google Scholar 

  13. Adhikari RP, Cook GM, Lamont I, et al.: Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2002, 50:825–831.

    Article  PubMed  CAS  Google Scholar 

  14. Mitchell JM, MacCulloch D, Morris A: MRSA in the community. N Z Med J 1996, 109:411.

    PubMed  CAS  Google Scholar 

  15. Maguire GP, Arthur AD, Boustead PJ, et al.: Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus in the Northern Territory. Med J Aust 1996, 164:721–723.

    PubMed  CAS  Google Scholar 

  16. Tambyah PA, Habib AG, Ng TM, et al.: Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually "healthcare associated". Infect Control Hosp Epidemiol 2003, 24:436–438.

    Article  PubMed  Google Scholar 

  17. Campbell AL, Bryant KA, Stover B, Marshall GS: Epidemiology of methicillin-resistant Staphylococcus aureus at a children’s hospital. Infect Control Hosp Epidemiol 2003, 24:427–430.

    Article  PubMed  Google Scholar 

  18. Thompson RL, Cabezudo I, Wenzel RP: Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982, 97:309–317.

    PubMed  CAS  Google Scholar 

  19. Jernigan JA, Pullen AL, Flowers L, et al.: Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol 2003, 24:409–414.

    Article  PubMed  Google Scholar 

  20. Nakamura MM, Rohling KL, Shashaty M, et al.: Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J 2002, 21:917–921.

    Article  PubMed  Google Scholar 

  21. Sa-Leào R, Santos Sanches I, Couto I, et al.: Low prevalence of methicillin-resistant strains among Staphylococcus aureus colonizing young and healthy members of the community in Portugal. Microb Drug Resist 2001, 7:237–245.

    Article  PubMed  Google Scholar 

  22. Saxena S, Singh K, Talwar V: Methicillin-resistant Staphylococcus aureus prevalence in community in the East Delhi area. Jpn J Infect Dis 2003, 56:54–56.

    PubMed  CAS  Google Scholar 

  23. Herold BC, Immergluck LC, Maranan MC, et al.: Communityacquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998, 279:593–598.

    Article  PubMed  CAS  Google Scholar 

  24. Bukharie HA, Abdelhadi MS, Saeed IA, et al.: Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diag Microbiol Infect Dis 2001, 40:1–4.

    Article  CAS  Google Scholar 

  25. Fergie JE, Purcell K: Community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J 2001, 20:860–863.

    Article  PubMed  CAS  Google Scholar 

  26. Purcell K, Fergie JE: Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J 2002, 21:988–989.

    Article  PubMed  Google Scholar 

  27. Seal JB, Moreira B, Bethel CD, Daum RS: Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: a 15-year longitudinal assessment in a large university-based hospital. Infect Control Hosp Epidemiol 2003, 24:403–408.

    Article  PubMed  Google Scholar 

  28. Nimmo GR, Bell JM, Mitchell D, et al.: Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989–1999. Microb Drug Resist 2003, 9:155–160.

    Article  PubMed  CAS  Google Scholar 

  29. Simor AE, Ofner-Agostini M, Bryce E, et al.: The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. Can Med Assoc J 2001, 165:21–26.

    CAS  Google Scholar 

  30. Naimi TS, LeDell KH, Boxrud DJ, et al.: Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996–1998. Clin Infect Dis 2001, 33:990–996.

    Article  PubMed  CAS  Google Scholar 

  31. Embil J, Ramotar K, Romance L, et al.: Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990–1992. Infect Control Hosp Epidemiol 1994, 15:646–651.

    Article  PubMed  CAS  Google Scholar 

  32. Hussain FM, Boyle-Vavra S, Bethel C, Daum RS: Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Inf Dis J 2000, 19:1163–1166.

    Article  CAS  Google Scholar 

  33. Centers for Disease Control and Prevention: Communityacquired methicillin-resistant Staphylococcus aureus infections-Michigan. MMWR Morb Mortal Wkly Rep 1981, 30:185–187.

    Google Scholar 

  34. Craven DE, Rixinger AI, Goularte TA, McCabe WR: Methicillinresistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a "shooting gallery". Am J Med 1986, 80:770–776.

    Article  PubMed  CAS  Google Scholar 

  35. Berman DS, Eisner W, Kreiswirth B: Community-acquired methicillin-resistant Staphylococcus aureus infection [letter]. N Engl J Med 1993, 329:1896.

    Article  PubMed  CAS  Google Scholar 

  36. Hollis RJ, Barr JL, Doebbeling BN, et al.: Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate. Clin Infect Dis 1995, 21:328–332.

    PubMed  CAS  Google Scholar 

  37. Grundmann H, Tami A, Hori S, et al.: Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community. Br Med J 2002, 324:1365–1366.

    Article  Google Scholar 

  38. Samad A, Banerjee D, Carbarns N, Ghosh S: Prevalence of methicillin-resistant Staphylococcus aureus colonization in surgical patients, on admission to a Welsh hospital. J Hosp Infect 2002, 51:43–46.

    Article  PubMed  CAS  Google Scholar 

  39. Rezende NA, Blumberg HM, Metzger BS, et al.: Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci 2002, 323:117–123.

    Article  PubMed  Google Scholar 

  40. Salmenlinna S, Lyytikàinen O, Vuopio-Varkila J: Communityacquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis 2002, 8:602–607.

    PubMed  Google Scholar 

  41. Blanc D, Pittet D, Ruef C, et al.: Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clones. Clin Microbiol Infect 2002, 8:419–426.

    Article  PubMed  CAS  Google Scholar 

  42. Sattler CA, Mason EO, Kaplan SL: Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002, 21:910–916.

    Article  PubMed  Google Scholar 

  43. Moreno F, Crisp C, Jorgenson JH, Patterson JE: Methicillinresistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995, 21:1308–1312.

    PubMed  CAS  Google Scholar 

  44. Groom AV, Wolsey JH, Naimi TS, et al.: Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001, 286:1201–1205.

    Article  PubMed  CAS  Google Scholar 

  45. Centers for Disease Control and Prevention: Outbreaks of community-acquired methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002–2003. MMWR Morb Mortal Wkly Rep 2003, 52:88.

    Google Scholar 

  46. Centers for Disease Control and Prevention: Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001, 50:919–922.

    Google Scholar 

  47. Landen MG, McCumber BJ, Asam ED, Egeland GM: Outbreak of boils in an Alaskan village: A case-control study. West J Med 2000, 172:235–239.

    Article  PubMed  CAS  Google Scholar 

  48. Charlebois ED, Bangsberg DR, Moss NM, et al.: Populationbased community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002, 34:425–433.

    Article  PubMed  Google Scholar 

  49. Zanelli G, Sansoni A, Zanchi A, et al.: Staphylococcus aureus nasal carriage in the community: a survey from central Italy. Epidemiol Infect 2002, 129:417–420.

    Article  PubMed  CAS  Google Scholar 

  50. Quagliarello B, Cespedes C, Miller M, et al.: Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis 2002, 35:671–677. This novel study combines ethnographic and molecular epidemiologic methods to investigate patterns of S. aureus transmission in a population of inhalation drug users. Use of both approaches facilitated the identification of transmission links, an epicenter, and vectors that might have been missed by the use of a single approach.

    Article  PubMed  Google Scholar 

  51. Lowy FD, Miller M: New methods to investigate infectious disease transmission and pathogenesis--Staphylococcus aureus disease in drug users. Lancet Infect Dis 2002, 2:605–612. This exciting article clearly describes the basics of social network theory and how it can be used with molecular epidemiologic techniques to construct complementary socially and biologically linked networks, yielding new insights into the spread of an infectious organism in the community setting.

    Article  PubMed  Google Scholar 

  52. Centers for Disease Control and Prevention: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus--Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep 1999, 48:707–710.

    Google Scholar 

  53. Gillet Y, Issartel B, Vanhems P, et al.: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359:753–759.

    Article  PubMed  CAS  Google Scholar 

  54. Baba T, Takeuchi F, Kuroda M, et al.: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002, 359:1819–1827. This article presents the sequence of the whole genome of MW2, a pediatric community MRSA isolate. The genes for at least 19 virulence factors distinct from those in comparison hospital-associated strains are described (including toxins, adhesins, and bacteriocins). Future studies may show these to be involved in the fulminance of infection or the widespread dissemination seen with related isolates.

    Article  PubMed  CAS  Google Scholar 

  55. Cheung AL, Projan SJ, Gresham H: The genomic aspect of virulence, sepsis, and resistance to killing mechanisms in Staphylococcus aureus. Curr Infect Dis Reports 2002, 4:400–410.

    Article  Google Scholar 

  56. Fey PD, Saïd-Salim B, Rupp ME, et al.: Comparative molecular analysis of community- or hospital-acquired methicillinresistant Staphylococcus aureus. Antimicrob Agents Chemother 2003, 47:196–203.

    Article  PubMed  CAS  Google Scholar 

  57. Dinges MM, Orwin PM, Schlievert PM: Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000, 13:16–34.

    Article  PubMed  CAS  Google Scholar 

  58. Cribier B, Prevost G, Couppié P, et al.: Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? Dermatology 1992, 185:175–180.

    Article  PubMed  CAS  Google Scholar 

  59. Lina G, Piémont Y, Godail-Gamot F, et al.: Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128–1132.

    Article  PubMed  CAS  Google Scholar 

  60. Dufour P, Gillet Y, Bes M, et al.: Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002, 35:819–824.

    Article  PubMed  CAS  Google Scholar 

  61. Gravet A, Couppié P, Meunier O, et al.: Staphylococcus aureus isolated in cases of impetigo produces both epidermolysins A or B and LukE-LukD in 78% of 131 retrospective and prospective cases. J Clin Microbiol 2001, 39:4349–4356.

    Article  PubMed  CAS  Google Scholar 

  62. Yamaguchi T, Yokota Y, Terajima J, et al.: Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis 2002, 185:1511–1516.

    Article  PubMed  CAS  Google Scholar 

  63. Andersson DI, Levin BR: The biological cost of antibiotic resistance. Curr Opin Microbiol 1999, 2:489–493.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, San Francisco General Hospital, University of California, 1001 Potrero Avenue, Box 0811, 94143, San Francisco, CA, USA

    Jose M. Eguia MD, MPH

Authors
  1. Jose M. Eguia MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henry F. Chambers MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eguia, J.M., Chambers, H.F. Community-acquired methicillin-resistant Staphylococcus aureus: Epidemiology and potential virulence factors. Curr Infect Dis Rep 5, 459–466 (2003). https://doi.org/10.1007/s11908-003-0087-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-003-0087-6

Keywords

Search

Navigation